XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2024   96,048,999          
Beginning balance at Dec. 31, 2024 $ 552,619 $ 96 $ (118,542) $ 910,237 $ (275,786) $ (1,180) $ 37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries 22,091       20,994   1,097
Other comprehensive income (loss) 1,525         1,525  
Stock options exercised (in shares)   8,333          
Stock options exercised 30     30      
Issuance of common stock for vesting of restricted stock units (in shares)   521,041          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   40,777          
Shares withheld related to net share settlement of share-based awards (in shares)   (174,157)          
Shares withheld related to net share settlement of share-based awards (670)     (670)      
Compensation expense for share-based awards 1,876     1,876      
Ending balance (in shares) at Jun. 30, 2025   96,444,993          
Ending balance at Jun. 30, 2025 577,471 $ 96 (118,542) 911,473 (254,792) 345 38,891
Beginning balance (in shares) at Mar. 31, 2025   96,171,702          
Beginning balance at Mar. 31, 2025 577,260 $ 96 (118,542) 910,688 (251,499) (518) 37,035
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (1,437)       (3,293)   1,856
Other comprehensive income (loss) 863         863  
Stock options exercised (in shares)   8,333          
Stock options exercised 30     30      
Issuance of common stock for vesting of restricted stock units (in shares)   276,412          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   40,777          
Shares withheld related to net share settlement of share-based awards (in shares)   (52,231)          
Shares withheld related to net share settlement of share-based awards (199)     (199)      
Compensation expense for share-based awards 954     954      
Ending balance (in shares) at Jun. 30, 2025   96,444,993          
Ending balance at Jun. 30, 2025 577,471 $ 96 (118,542) 911,473 (254,792) 345 38,891
Beginning balance (in shares) at Dec. 31, 2025   96,475,469          
Beginning balance at Dec. 31, 2025 584,032 $ 96 (118,542) 915,330 (254,104) 670 40,582
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (26,043)       (15,694)   (10,349)
Other comprehensive income (loss) (90)         (90)  
Issuance of common stock for vesting of restricted stock units (in shares)   1,758,841          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   21,008          
Shares withheld related to net share settlement of share-based awards (in shares)   (668,513)          
Shares withheld related to net share settlement of share-based awards (3,096) $ (1)   (3,095)      
Compensation expense for share-based awards 2,216     2,216      
Ending balance (in shares) at Jun. 30, 2026   97,586,805          
Ending balance at Jun. 30, 2026 557,021 $ 97 (118,542) 914,451 (269,798) 580 30,233
Beginning balance (in shares) at Mar. 31, 2026   96,589,132          
Beginning balance at Mar. 31, 2026 567,225 $ 96 (118,542) 916,010 (269,845) 784 38,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (8,442)       47   (8,489)
Other comprehensive income (loss) (204)         (204)  
Issuance of common stock for vesting of restricted stock units (in shares)   1,587,545          
Issuance of common stock for vesting of restricted stock units and performance based stock awards 2 $ 2          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   10,613          
Shares withheld related to net share settlement of share-based awards (in shares)   (600,485)          
Shares withheld related to net share settlement of share-based awards (2,776) $ (1)   (2,775)      
Compensation expense for share-based awards 1,216     1,216      
Ending balance (in shares) at Jun. 30, 2026   97,586,805          
Ending balance at Jun. 30, 2026 $ 557,021 $ 97 $ (118,542) $ 914,451 $ (269,798) $ 580 $ 30,233